Skip to main content
[Preprint]. 2023 Nov 11:2023.11.07.566063. [Version 1] doi: 10.1101/2023.11.07.566063

Figure 2: Multiplexed subcellular imaging of cell line models reveals primary and micronuclear rupture are associated with distinctive protein expression patterns.

Figure 2:

A, Experimental overview. Human RPE cells were treated with LMNB1 siRNA, MPS1i, or X-ray radiation (2Gy), to induce PN or MN rupture then analyzed using plate-based CyCIF. B, Representative images of each treatment group (arrows, MN rupture; arrowheads, PN rupture). C, Quantification of BAF-positive PN and MN ruptures following treatment (mean % of cells +/− S.D) (*p<0.05) (t-test, two-sided, unpaired). D, p-CyCIF images of a ruptured, BAF-positive PN bleb in cells treated with LMNB1 siRNA, showing localized disorganization and accumulation of lamin A/C and emerin, reduced levels of lamin B1/B2 and NUP133, and absence of pH2AX, LBR, and STING. E, Percentage of BAF-negative or BAF-positive PN blebs in LMNB1-kd cells expressing each intensity of a given marker, based on semi-quantitative visual scoring (t-test, two-sided, unpaired). F, p-CyCIF images of a ruptured, BAF-positive micronucleus a cell treated with MPS1 inhibitor, exhibiting low lamin A/C, lamin B1/B2, and NUP133, and accumulation of emerin, LBR, pH2AX, cGAS, and STING. G, Percentage of BAF-negative or BAF-positive MN expressing each intensity of a given marker in MPS1i-treated cells, based on semi-quantitative visual scoring (t-test, two-sided, unpaired). H, Representative images of XR-treated cells with PN and MN ruptures associated with accumulation of cGAS and/or pH2AX. I, Representative images of XR-treated cells with occasional pH2AX-positive PN blebs. J,K, Percentage of BAF-negative or BAF-positive PN (J) or MN (K) with a given expression level of indicated markers. L, Representative p-CyCIF images of STING in RPE cells per condition (arrowheads, STING foci). M, Quantification STING foci in each experimental condition (*p<0.05, ***p=0.0503) (t-test, two-sided, unpaired).